Predictive factors of severe early treatment-related toxicity in patients receiving first-line treatment for metastatic colorectal cancer: Pooled analysis of 2190 patients enrolled in Fédération Francophone de Cancérologie Digestive (FFCD) trials-Reference-Cited by-同舟云学术

Predictive factors of severe early treatment-related toxicity in patients receiving first-line treatment for metastatic colorectal cancer: Pooled analysis of 2190 patients enrolled in Fédération Francophone de Cancérologie Digestive (FFCD) trials

Published:2021-08 Issue: Volume:153 Page:40-50
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Breton Clémence^ORCID,Aparicio Thomas^ORCID,Le Malicot Karine^ORCID,Ducreux Michel,Lecomte Thierry,Bachet Jean-Baptiste,Taieb Julien,Legoux Jean-Louis,De Gramont Aimery,Benouna Jaafar,Bouché Olivier,Boussari Olayide,Manfredi Sylvain,Gornet Jean-Marc

Funder

Novartis

Servier

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference19 articles.

1. Clinical determinants of survival in patients with 5-fluorouracil- based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients;Köhne;Ann Oncol,2002

2. Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR study;Chibaudel;Oncologist,2011

3. Quality of life of patients with gastrointestinal cancers undergoing chemotherapy;Tantoy;Qual Life Res Int J Qual Life Asp Treat Care Rehabil,2018

4. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study;de Gramont;J Clin Oncol Off J Am Soc Clin Oncol,1997

5. Randomised trial comparing three different schedules of infusional 5FU and raltitrexed alone as first-line therapy in metastatic colorectal cancer. Final results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 trial;Ducreux;Oncology,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotoxicity and Associated Risk Factors in Colorectal Cancer: A Systematic Review and Meta-Analysis;Cancers;2024-07-20

2. Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis;British Journal of Cancer;2024-01-15

3. Predicting Severe Haematological Toxicity in Gastrointestinal Cancer Patients Undergoing 5-FU-Based Chemotherapy: A Bayesian Network Approach;Cancers;2023-08-22

4. Carcinoembryonic antigen kinetics predict response to first-line treatment in metastatic colorectal cancer: Analysis from PRODIGE 9 trial;Digestive and Liver Disease;2023-06